.jpg)
CDC slightly increases risk bird flu could cause a pandemic in latest assessment
The Centers for Disease Control and Prevention issued a new risk assessment of the H5N1…
Category: Life Sciences
Opinion: Noah Lyles collapse with Covid: How not to manage health at the Olympics
Noah Lyles, a 27-year-old from Gainesville, Florida, has had himself quite an Olympics. He won…
DO NOT PUBLISH: FDA rejects MDMA as a psychedelic treatment for PTSD
The Food and Drug Administration rejected MDMA as a treatment for post-traumatic stress disorder on…
Why Trump’s mifepristone comments were a gift to the Harris campaign
WASHINGTON — Former President Trump doesn’t want to talk much about abortion in his 2024 presidential…
FDA approves EpiPen alternative, a nasal spray for anaphylaxis
On Friday, the Food and Drug Administration approved the first needle-free treatment for adults and…
Morning Rounds: Another Ebola outbreak?
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…
Why did Novo pull heart failure paperwork for Wegovy?
Hey, humans. Today, we talk about the decades-long pursuit to get MDMA approved as a…
STAT+: Pharmalittle: We’re reading about a California bill to restrain PBMs, a U.K. trade group scolding Novo, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: A bespoke genetic therapy is helping Susannah. Can similar drugs be made at scale for other rare diseases?
Will it work? It was the question everyone around Susannah Rosen kept asking. Since infancy,…
MDMA therapy is facing an imminent FDA decision. Here’s what you need to know
A decades-long campaign to legalize MDMA as a mainstream medical treatment will reach a climax…
Opinion: Medicine needs fiction, especially now
The American medical system needs fiction because, as Albert Camus supposedly said, “Fiction is the…
STAT+: Medicare paid substantially more for J&J’s Stelara when it was covered under Part D than under Part B
A popular biologic medicine used to combat autoimmune diseases cost Medicare and its beneficiaries considerably…
.jpg)
STAT+: Judge rules against Chamber of Commerce in Medicare drug negotiation lawsuit
WASHINGTON — A federal judge on Thursday tossed out a U.S. Chamber of Commerce lawsuit…
STAT+: A U.K. trade group scolds Novo again — this time for remarks made by its CEO
Once again, Novo Nordisk has been admonished by a U.K. trade group for violating voluntary…
How experiencing famine in the womb may shape people’s health as adults
Hunger killed an estimated 4 million people in Ukraine between 1932 and 1933 — the…
STAT+: AI app claiming to diagnose STIs from penis pictures shut down after FTC scrutiny
The company that claimed its AI model could identify sexually transmitted infections from a single…
STAT+: Big Health gets FDA nod for its digital therapy for insomnia
Digital Therapeutics developer Big Health this week received Food and Drug Administration clearance for SleepioRx,…
As Covid deaths drop, heart disease and cancer remain leading causes of death
Since its emergence in 2020, Covid has jumbled the list of the 10 leading causes…
Listen: VC struggles, drug pricing negotiations, & Novo’s abrupt Wegovy decision
Why did Novo Nordisk pull its paperwork to expand the use of Wegovy for a…
Talkspace earnings, a framework for detecting AI hallucination, and trends in telehealth abortions
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology…
STAT+: A strong start for Madrigal’s MASH drug launch
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can…
STAT+: Pharmalittle: We’re reading about a Purdue overdose-reversal device, a discontinued Merck trial, and more
Top of the morning to you, and a fine one it is, despite the gray…
STAT+: AI drug developers Recursion, Exscientia to merge
Two of the leading companies in the AI drug development field, Recursion Pharmaceuticals and Exscientia,…
Sarepta CEO: We’re ‘pretty brilliant’
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Eli Lilly boosts 2024 revenue guidance by $3 billion on Mounjaro, Zepbound sales
Eli Lilly raised its full-year revenue guidance by $3 billion, driven by massive sales of…
Opinion: Removing barriers to split liver transplants will save lives
The liver is one of the few organs that need not be transplanted whole. It…
Scientists are starting to uncover how neighborhood can affect the biology of cancer
Where you live has a relationship to your odds of getting cancer and surviving cancer….
Trump’s real health care agenda isn’t in Project 2025 — it’s in his own words
WASHINGTON — Former President Trump has made it abundantly clear that nobody else speaks for…
Watch: How drug patents pave the way to profit
This is Part 3 of “Behind the Counter,” an in-depth video series demystifying the complex…
STAT+: Orlando Health, a $6 billion Florida powerhouse, is expanding into Alabama
As for-profit Tenet Healthcare slims its hospital portfolio, it found an unlikely buyer for its…
FDA approves Purdue Pharma’s controversial new overdose-reversal medication
Purdue Pharma, the company best known for fueling the opioid crisis by misleadingly marketing the…
Source credibility: a necessary North Star in cancer care – Nature.com
Source credibility: a necessary North Star in cancer care Nature.com Read Original Article: Source credibility: a…
STAT+: Vertex, U.K. reach deal to provide CRISPR-based medicine to thalassemia patients in England
LONDON — Patients in England with a rare blood disorder will now be able to…
STAT+: Medicare finalizes reimbursement rule for breakthrough medical devices
The Centers for Medicare and Medicaid Services has finalized its rule easing reimbursement for medical…
The dark side of Medicare Advantage: a must-read investigation
Dear Readers, If you read anything this year exposing the hidden injustices in our health…
STAT+: CVS removes top Aetna leader as higher medical costs eat further into profits
CVS Health continued to pay out more than it expected for the medical claims of…
STAT+: The race to build better CRISPR delivery vehicles is heating up
If the first CRISPR decade was marked by a mad dash to evolve, engineer, and…
STAT+: FDA scolds Bristol Myers over a misleading website for a cancer treatment
The U.S. Food and Drug Administration has scolded Bristol Myers Squibb for making false and…
WHO to convene panel to determine whether mpox outbreak is a public health emergency
The director general of the World Health Organization announced Wednesday that he will convene a…
STAT+: Pharmalittle: We’re reading about Roche plans for Flatiron, underwhelming Novo Nordisk earnings, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
STAT+: Novo Nordisk pulls filings for Wegovy in heart failure as it waits for cardiovascular outcomes data
Novo Nordisk is pulling its regulatory submissions to expand the use of its obesity drug…
A new drug for glioma means a windfall for Agios
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Trump keeps losing his train of thought. Cognitive experts have theories about why
In a speech earlier this year, former President Trump was mocking President Biden’s ability to…
Opinion: Give pharmaceutical execs the benefit of doubt — but they need to work for it
The polarized debate over drug pricing has generated cartoonish, sometimes colorful caricatures of the biopharmaceutical…
STAT+: How UnitedHealth turned a questionable artery-screening program into a gold mine
The nation’s largest health care company pressed thousands of its clinicians to use a thinly…
Opinion: When life mirrors research: What a fall on the ice taught me about being Black and in pain
As I hurried to an important meeting about my Ph.D. dissertation one day in 2015,…
STAT+: Supply issues weigh on Novo Nordisk as drugmaker stumbles with quarterly report
LONDON — An underwhelming earnings report and ongoing questions about increasing competition in the booming…
Alternative Treatments and In-Office Samples for Atopic Dermatitis Management – Dermatology Times
Alternative Treatments and In-Office Samples for Atopic Dermatitis Management Dermatology Times Read Original Article: Alternative Treatments…
Medicare alternative payment models – American Medical Association
Medicare alternative payment models American Medical Association Read Original Article: Medicare alternative payment models – American…
Want to know how to get rid of a Hangover? Try Realistic Wellness solutions like Jelly IV – USA TODAY
Want to know how to get rid of a Hangover? Try Realistic Wellness solutions like…